Northern Trust
KRRO icon

Northern Trust’s Korro Bio KRRO Stock Holding History

Northern Trust’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Buy
57,702
+2,062
+4% +$22.7K ﹤0.01% 3505
2025
Q4 		$446K Sell
55,640
-1,633
-3% -$38.2K ﹤0.01% 3695
2025
Q3 		$2.74M Sell
57,273
-595
-1% -$13.2K ﹤0.01% 2856
2025
Q2 		$723K Sell
57,868
-343
-0.6% -$4.94K ﹤0.01% 3527
2025
Q1 		$1.01M Sell
58,211
-2,336
-4% -$69.3K ﹤0.01% 3273
2024
Q4 		$2.31M Buy
60,547
+2,717
+5% +$140K ﹤0.01% 2942
2024
Q3 		$1.93M Buy
57,830
+42,548
+278% +$1.79M ﹤0.01% 3024
2024
Q2 		$518K Buy
15,282
+4,989
+48% +$276K ﹤0.01% 3497
2024
Q1 		$926K Sell
10,293
-217
-2% -$11.8K ﹤0.01% 3341
2023
Q4 		$504K Buy
10,510
+9,311
+777% +$307K ﹤0.01% 3536
2023
Q3 		$22.2K Hold
1,199
– – ﹤0.01% 4315
2023
Q2 		$20.8K Hold
1,199
– – ﹤0.01% 4405
2023
Q1 		$30.2K Sell
1,199
-14
-1% -$1.59K ﹤0.01% 4372
2022
Q4 		$234K Hold
1,213
– – ﹤0.01% 3798
2022
Q3 		$108K Hold
1,213
– – ﹤0.01% 4089
2022
Q2 		$91K Sell
1,213
-4,247
-78% -$287K ﹤0.01% 4209
2022
Q1 		$579K Sell
5,460
-277
-5% -$52.9K ﹤0.01% 3682
2021
Q4 		$1.47M Sell
5,737
-1,670
-23% -$508K ﹤0.01% 3376
2021
Q3 		$2.61M Buy
7,407
+973
+15% +$383K ﹤0.01% 3135
2021
Q2 		$3.21M Sell
6,434
-802
-11% -$392K ﹤0.01% 3112
2021
Q1 		$3.44M Buy
7,236
+928
+15% +$1.8M ﹤0.01% 2973
2020
Q4 		$11.1M Sell
6,308
-44
-0.7% -$58.1K ﹤0.01% 2184
2020
Q3 		$6.1M Buy
6,352
+55
+0.9% +$59K ﹤0.01% 2407
2020
Q2 		$7.32M Buy
6,297
+4,746
+306% +$4.29M ﹤0.01% 2287
2020
Q1 		$1.38M Buy
1,551
+65
+4% +$70.2K ﹤0.01% 3055
2019
Q4 		$1.3M Buy
+1,486
New +$1.16M ﹤0.01% 3309

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Northern Trust's KRRO Position: Q1 2026 in Review

Northern Trust increased its Korro Bio (KRRO) stake by 3.7% in Q1 2026, buying an estimated $22.7K and bringing the position to 57,702 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #3505.

Northern Trust first reported a position in KRRO in Q4 2019 and has held it in 26 quarters since. The position peaked at $11.1M in Q4 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Northern Trust held 57,702 shares of Korro Bio worth $653K as of Q1 2026.
  • Northern Trust bought 2,062 Korro Bio shares in Q1 2026, an estimated $22.7K.
  • Korro Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3505 holding.
  • Northern Trust first reported a position in Korro Bio in Q4 2019 and has held it in 26 quarters since.
  • Northern Trust's Korro Bio position peaked at $11.1M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.